{"database": "lobbying", "table": "lobbying_activities", "rows": [[2350815, "7458a6e8-bda7-4964-8dc5-d23f289163a7", "Q3", "HIGHMARK, INC.", 18238, "HIGHMARK INC", 2019, "third_quarter", "PHA", "(Epidemic, Deterrence); CREATES Act; Drug Pricing; PBM/Prescription Drug Costs; Rx Rebates; Biosimilars; Drug approval; Drug patents\n\nH.R.1781 - Payment Commission Data Act of 2019 Sponsor: Rep. Carter, Earl L. \"Buddy\" [R-GA-1]\n\nH.R.938 -BLOCKING Act of 2019\nSponsor: Rep. Schrader, Kurt [D-OR-5]\n\nH.R.1520 - Purple Book Continuity Act of 2019 Sponsor: Rep. Eshoo, Anna G. [D-CA-18]\n\nH.R.1503 Orange Book Transparency Act of 2019 Sponsor: Rep. Kelly, Robin L. [D-IL-2]\n\nH.R.1499 - Protecting Consumer Access to Generic Drugs Act of 2019 Sponsor: Rep. Rush, Bobby L. [D-IL-1]\n\nH.R.965 CREATES Act of 2019\nSponsor: Rep. Cicilline, David N. [D-RI-1]\n\nH.R.3 - Lower Drug Costs Now Act of 2019 Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6]\n\nH.R.275 - Medicare Prescription Drug Price Negotiation Act of 2019 Sponsor: Rep. Welch, Peter [D-VT-At Large]\n\nH.R.448 - Medicare Drug Price Negotiation Act Sponsor: Rep. Cummings, Elijah E. [D-MD-7]\n\nH.R.1046 - Medicare Negotiation and Competitive Licensing Act of 2019 Sponsor: Rep. Doggett, Lloyd [D-TX-35]", "HOUSE OF REPRESENTATIVES,SENATE", null, 300000, 0, 0, "2019-10-18T11:48:06.357000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2350815"], "units": {}, "query_ms": 23.99162098299712, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}